Orchid Pharma Equity Shares Listed on NSE & BSE Post Amalgamation

Orchid Pharma Ltd has announced the successful listing and admission to dealings of 4,45,86,052 equity shares on the National Stock Exchange (NSE) and BSE Limited. These shares were issued and allotted pursuant to the Scheme of Amalgamation sanctioned by the Hon'ble National Company Law Tribunal, Chennai Bench. The trading of these new equity shares commenced effective September 23, 2026. This development marks a significant step following the company's earlier intimation on August 01, 2026, regarding the allotment.